Sclerosis News and Research

RSS

ASU professor offers insights on what may be coming from Neuralink’s PRIME study

This week, Neuralink's Elon Musk announced that human clinical trials have begun on its Precise Robotically Implanted Brain-Computer Interface (PRIME) study, a medical device trail that uses wireless, brain-computer interface designed to enable people with paralysis to control external devices with their thoughts.

2 Feb 2024

Phase II clinical trial evaluates the safety and efficacy of a Muse cell-based product in patients with ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor functions, which eventually leads to death within 5 years of its onset.

1 Feb 2024

Study shows nuanced pregnancy outcomes for pregnant individuals with autoimmune disease

For many aspiring mothers with autoimmune disease, pregnancy can be daunting and full of unknowns. In some cases, those suffering from specific autoimmune conditions have chosen to forego pregnancy altogether due to concerns about their disease treatments and adverse pregnancy outcomes.

1 Feb 2024

Next-gen BTK degrader could help overcome treatment resistance in chronic lymphocytic leukemia

New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations has identified a next-generation BTK degrader that could help overcome treatment resistance in chronic lymphocytic leukemia (CLL) and related blood cancers.

1 Feb 2024

X-chromosome inactivation and its role in autoimmune susceptibility in females

Somewhere between 24 and 50 million Americans have an autoimmune disease, a condition in which the immune system attacks our own tissues. As many as 4 out of 5 of those people are women.

1 Feb 2024

People with polycystic ovary syndrome may have memory and thinking problems in midlife

People with polycystic ovary syndrome may be more likely to have memory and thinking problems in middle age, according to new research published in the January 31, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Feb 2024

Study shows link between moderate radon exposure and increased risk of stroke

Radon is the second leading cause of lung cancer. Now a new study has found exposure to this invisible, odorless gas is also linked to an increased risk of stroke.

1 Feb 2024

Researchers discover non-opioid therapeutic for relieving neuropathic pain

Among the most difficult types of pain to alleviate is neuropathic pain, pain that is usually caused by damage to nerves in various body tissues, including skin, muscle and joints.

31 Jan 2024

Hot spring baths shown to boost gut health, study finds

Researchers discovered that bathing in Japanese hot springs significantly alters the gut microbiota in healthy individuals, offering potential health benefits by increasing certain beneficial bacteria. This is the first study to explore the distinct effects of different hot spring types on the gut microbiome.

30 Jan 2024

Weill Cornell Medicine researcher wins $2.1 million grant to study repetitive DNA and RNA sequences

Dr. Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.

30 Jan 2024

Henry Ford Health and MSU continue groundbreaking medical research initiative

Michiganders will continue to have the opportunity to advance medical research aimed at advancing individualized health care through a renewed award to Henry Ford Health + Michigan State University Health Sciences from the National Institutes of Health's (NIH) All of Us Research Program.

29 Jan 2024

Fasting diets show promise in enhancing mood, sleep, and eating behaviors

A study in "Frontiers in Nutrition" reveals that fasting diets (FDs) may positively impact eating behaviors, mood, sleep, and well-being, potentially mediated by gut microbiome changes.

28 Jan 2024

UCL's neuro research to be supported by e-money venture Science Card

A UCL research team developing an artificial fiber technology to accelerate neurodegenerative disease clinical trials will be one of the first studies supported by e-money venture Science Card.

25 Jan 2024

Study looks at ways to more accurately predict when migraine attack will occur

Migraine is often underdiagnosed and untreated, and even when it is treated, it can be difficult to treat early enough as well as find strategies to prevent attacks.

24 Jan 2024

Genomics meets retinal imaging: A powerful fusion can predict future health

The retina is said to provide a window into a person's systemic health. In a new study published January 24th in Science Translational Medicine, physician-researchers from Mass Eye and Ear, a member of Mass General Brigham, and the Broad Institute of MIT and Harvard combined retinal imaging, genetics and big data to estimate how likely a person is to develop eye and systemic diseases in the future.

24 Jan 2024

European consortium awarded €6.5M to study psychedelic-assisted therapy

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

24 Jan 2024

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

From Calluna Pharma 24 Jan 2024

Sclerosis News and Research

ASU professor offers insights on what may be coming from Neuralink’s PRIME study

Phase II clinical trial evaluates the safety and efficacy of a Muse cell-based product in patients with ALS

Study shows nuanced pregnancy outcomes for pregnant individuals with autoimmune disease

Next-gen BTK degrader could help overcome treatment resistance in chronic lymphocytic leukemia

X-chromosome inactivation and its role in autoimmune susceptibility in females

People with polycystic ovary syndrome may have memory and thinking problems in midlife

Study shows link between moderate radon exposure and increased risk of stroke

Researchers discover non-opioid therapeutic for relieving neuropathic pain

Hot spring baths shown to boost gut health, study finds

Weill Cornell Medicine researcher wins $2.1 million grant to study repetitive DNA and RNA sequences

Henry Ford Health and MSU continue groundbreaking medical research initiative

Fasting diets show promise in enhancing mood, sleep, and eating behaviors

UCL's neuro research to be supported by e-money venture Science Card

Study looks at ways to more accurately predict when migraine attack will occur

Genomics meets retinal imaging: A powerful fusion can predict future health

European consortium awarded €6.5M to study psychedelic-assisted therapy

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Young Black and Hispanic women with multiple sclerosis fare worse than white women

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

The Mediterranean Diet may be able to improve your sleep

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News